IP Library Granted Patent US 11,064,894
Granted Patent B2
US 11,064,894 · App. 16/106,189 · Granted Jul 20, 2021

Method and device to manage fluid volumes in the body

Inventors: Orhan Soykan (Shoreview, MN); Christopher M. Hobot (Rogers, MN); Martin T. Gerber (Maple Grove, MN); VenKatesh R. Manda (Stillwater, MN)
Assignee: Medtronic, Inc.
A61B5/021A61B5/0205A61B5/02405A61B5/053A61B5/08A61B5/14552A61B5/201A61B5/361A61B5/4848A61B5/4875A61B5/7246A61B5/7264A61M1/1603A61M1/282A61M1/3403G06F19/00G16H10/60G16H20/40G16H40/63G16H50/20G16H50/50A61B5/4806A61M2205/3523
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,064,894
App. No.
16/106,189
Granted
Jul 20, 2021
Kind
B2
Abstract

A system and method for determining the amount of fluid to be removed from a dialysis patient is disclosed. The system utilizes sensors and a computer. The computer obtains the input parameters from the sensors, along with information added directly by the user, and performs a forward algorithm to determine a recommended change in patient fluid level. As fluid is removed, the effect of the removal on the parameters is detected by the sensors and re-transmitted back to the computer. The computer then performs a backward algorithm to refine the variables used in the forward algorithm and obtain more accurate results. The system and method provide for changing the amount of fluid removed from the patient based on the results of the algorithm and the data received from the sensors.

Claims (8)

1. A method, comprising the steps of:

connecting a patient to a medical device to obtain input parameters correlated for fluid removal;

transferring the input parameters to a medical device processor having a shielded circuitry to reduce electric shock to the patient, wherein the medical device processor is implemented with a forward algorithm to generate a recommended fluid level (DFL) based on the input parameters, and wherein the forward algorithm is presented by the equation:

DFL=W 1* D 1( P 1, X 1)+ W 2* D 2( P 2, X 2)+ W 3* D 2( P 3, X 3)+ W 4* D 1( P 4, X 4)+ W 5* D 1( P 5, X 5)+ W 6* D 2( P 6, X 6)+ W 7* D 2( P 7, X 7)+ W 8* D 2( P 8, X 8)+ W 9* D 2( P 9, X 9)+ W 10* D 2( P 10, X 10)+ W 12* D 1( P 12, X 12)+ W 13* D 1( P 13, X 13)+ W 14* D 2( P 14, X 14)+ W 15* D 1( P 15, X 15)+ W 16* D 1( P 16, X 16);

where P1 through P16 are each an input parameter, W1 through W16 are each a weighting coefficient predetermined according to a level of impact on fluid removal by a corresponding input parameter, X1 through X16 are each a cut-off trigger predetermined when a corresponding input parameter indicates no recommended change in fluid level, D1 is a function with an output of either 0 and 1 and increases from 0 to 1 as the value of the input parameter increases to a value greater than its corresponding cut-off trigger, D2 is a function with an output is either 0 or 1 and deceases from 1 to 0 as the value of an input parameter is greater than the value of the cut-off trigger, where input parameters associated with D1 correlate to an excess of fluid in the patient when increased and the input parameters associated with D2 correlate to an excess of fluid in the patient when decreased; and

adjusting fluid removal from the patient based on the recommended fluid level.

2. The method of claim 1 , wherein the one or more parameters positively correlated for fluid removal are selected from the group consisting of atrial fibrillation burden, respiratory rate, sleep pattern, dialysis markers, patient weight, patient medications and dosage, patient supplied data indicative of fluid removal, and clinical data indicative of fluid removal.

3. The method of claim 1 , wherein the one or more parameters negatively correlated for fluid removal are selected from the group consisting of tissue impedance, ambulatory heart rate variability, body temperature, heart rate change during dialysis, heart rate variability during dialysis, blood pressure reduction during dialysis, mixed venous oxygen saturation, and patient medications and dosage indicative of fluid retention.

Assignments (3)
SECURITY INTEREST Recorded Dec 1, 2025
From: MOZARC MEDICAL US LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V, LP
Reel/Frame 073800/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2023
From: MEDTRONIC, INC.
To: MOZARC MEDICAL US LLC
Reel/Frame 063375/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2018
From: SOYKAN, ORHAN; GERBER, MARTIN T.; HOBOT, CHRISTOPHER M.; MANDA, VENKATESH R.
To: MEDTRONIC, INC.
Reel/Frame 046639/0584 →
Continuity (3)
Continuation 14539437 · Nov 12, 2014
Provisional Application 61899875 · Nov 4, 2013
Related Publication 20180353136A1 · Dec 13, 2018